How should I evaluate and manage a patient with anemia presenting as low hemoglobin but normal iron studies?

Evaluation and Management of Low Hemoglobin with Normal Iron Studies

Immediate Diagnostic Workup

When a patient presents with anemia but normal iron studies, you must immediately obtain a reticulocyte count to differentiate impaired bone marrow production from hemolysis or acute blood loss. 1

Essential First-Line Laboratory Tests

• Order an absolute reticulocyte count (or reticulocyte index) to determine whether the bone marrow is responding appropriately to the anemia. 1, 2
• Obtain a peripheral blood smear to evaluate red cell morphology, identify hypersegmented neutrophils (suggesting B12/folate deficiency), schistocytes (suggesting hemolysis), or other diagnostic features. 1
• Measure serum vitamin B12 and folate levels to exclude megaloblastic anemia, particularly if the MCV is elevated or high-normal. 1
• Check thyroid-stimulating hormone (TSH) to rule out hypothyroidism, a common reversible cause of anemia that mimics erythropoietin deficiency. 1
• Assess renal function with serum creatinine and estimated glomerular filtration rate (eGFR) to identify chronic kidney disease as a source of erythropoietin deficiency. 1, 3

Algorithm Based on Reticulocyte Count

Low or Normal Reticulocyte Count (< 2%)

A low or inappropriately normal reticulocyte count indicates inadequate bone marrow response and directs evaluation toward nutritional deficiencies, chronic disease, or primary marrow disorders. 1, 2

If MCV is Low-Normal or Microcytic (< 80 fL):

• Re-examine iron studies in the context of inflammation: Measure C-reactive protein (CRP) alongside ferritin, because inflammation can falsely elevate ferritin and mask true iron deficiency. 1, 2
• If CRP is elevated and transferrin saturation < 15–20%, the patient likely has functional iron deficiency (anemia of chronic disease with iron restriction) despite "normal" ferritin. 1, 2
• Consider thalassemia trait if MCV is markedly low (< 75 fL), RDW is normal or only slightly elevated (< 14%), and iron studies remain truly normal; order hemoglobin electrophoresis, especially in patients of Mediterranean, African, Middle Eastern, or Southeast Asian descent. 1

If MCV is Normocytic (80–100 fL):

• Evaluate for chronic kidney disease: Serum creatinine ≥ 2 mg/dL with normocytic anemia and no other identifiable cause strongly suggests erythropoietin deficiency. 1, 3
• Screen for anemia of chronic disease: Assess for underlying inflammatory conditions (rheumatoid arthritis, inflammatory bowel disease, chronic infections, malignancy) that suppress erythropoiesis. 1
• Consider bone marrow evaluation if initial workup is nondiagnostic and pancytopenia is present, to exclude aplastic anemia or myelodysplastic syndrome. 1

If MCV is Macrocytic (> 100 fL):

• Measure vitamin B12 and folate levels immediately to confirm or exclude megaloblastic anemia. 1
• Review medication history for thiopurines (azathioprine, 6-mercaptopurine), chemotherapy agents, anticonvulsants, or methotrexate, all of which can induce macrocytosis. 1
• Assess for gastrointestinal malabsorption (celiac disease, inflammatory bowel disease, prior gastric surgery) that raises the risk of B12 deficiency. 1
• If B12 and folate are normal, check TSH and liver function tests, and consider bone marrow referral if no cause is identified. 1

Elevated Reticulocyte Count (> 2%)

An elevated reticulocyte count indicates an appropriate marrow response and points to hemolysis or acute blood loss. 1

Hemolysis Evaluation:

• Order a hemolysis panel: Low haptoglobin, elevated lactate dehydrogenase (LDH), elevated indirect bilirubin, and peripheral smear for schistocytes or spherocytes. 1
• Perform a direct antiglobulin (Coombs) test to identify autoimmune hemolytic anemia. 1
• If the initial hemolysis workup is nondiagnostic, consider paroxysmal nocturnal hemoglobinuria flow cytometry, disseminated intravascular coagulation panel, and screening for viral or bacterial infections. 1

Acute Blood Loss Assessment:

• Obtain stool guaiac or fecal immunochemical test to detect occult gastrointestinal bleeding. 1
• Evaluate for other sources of bleeding (menstrual, urinary, retroperitoneal) based on clinical context. 1

Critical Pitfalls to Avoid

• Do not interpret ferritin without concurrent CRP measurement, because inflammation, infection, or malignancy can artificially elevate ferritin and mask true iron deficiency. 1, 2
• Do not assume "normal" iron studies exclude iron deficiency in the presence of chronic inflammation; transferrin saturation < 15–20% is the primary indicator when CRP is elevated. 1, 2
• Do not overlook mixed deficiencies: Simultaneous iron and vitamin B12/folate deficiencies can neutralize the MCV while producing an elevated RDW; both iron and vitamin studies must be ordered. 1
• Do not delay bone marrow evaluation in patients with pancytopenia, as this may indicate aplastic anemia or myelodysplastic syndrome requiring urgent hematology referral. 1

Management Based on Underlying Etiology

Anemia of Chronic Disease:

• Treat the underlying inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease, chronic infection). 1
• Consider erythropoietin therapy in specific situations such as chronic kidney disease with hemoglobin < 10 g/dL and inadequate response to iron. 1, 3

Chronic Kidney Disease:

• Routine measurement of serum erythropoietin levels is generally not indicated in CKD-related anemia. 1, 3
• For CKD patients not on dialysis with TSAT ≤ 30% and ferritin ≤ 500 ng/mL, consider a 1–3 month trial of oral or intravenous iron. 1, 3

Vitamin B12 or Folate Deficiency:

• Initiate oral folate supplementation for folate deficiency, but be aware that high-dose folic acid may mask B12 deficiency symptoms. 1
• Treat B12 deficiency with intramuscular or high-dose oral B12, depending on the cause (pernicious anemia, malabsorption, dietary insufficiency). 1

Hemolysis:

• Management depends on the specific hemolytic disorder identified (autoimmune hemolytic anemia, hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria, etc.) and typically requires hematology consultation. 1

When to Refer to Hematology

• Pancytopenia or unexplained cytopenias in other lineages warrant urgent hematology referral for possible bone marrow biopsy. 1
• Hemolysis confirmed on laboratory testing should prompt hematology consultation for further characterization and management. 1
• Anemia refractory to appropriate treatment (e.g., persistent anemia despite adequate iron, B12, or folate repletion) requires specialist evaluation. 1, 4
• Suspected thalassemia trait or other hemoglobinopathy should be confirmed with hemoglobin electrophoresis and genetic counseling if indicated. 1